@BowtellLab

Understanding the Genomic Characterisation of Ovarian Cancer 🔬Cancer Genomics and Genetics @PeterMacRes @PeterMacCC @PrDavidBowtell

 Parkville, Melbourne
Joined July 2019
  • Tweets163
  • Following150
  • Followers454
6Media
Interested in hearing more about the #ovariancancer research going on at @PeterMacCC by @BowtellLab and our colleagues in @PeterMacRes #benchtobedside? Check out the Peter Mac Spotlight Series 👇🔬🥼
Peter Mac Cancer Centre@PeterMacCC4 Mar 2021
In the first Peter Mac Spotlight Series you’ll hear from @PrDavidBowtell @DaleGarsed @kylie_gorringe @elaine_sanij & @g_auyeung and their groundbreaking work that's leading to new hope for women with #ovariancancer across the globe. Click and listen now. petermac.org/news/spotlight-…
1
4
11
Hot off the press: 📣 the latest from our work unravelling the secrets behind exceptional responses to treatment for #ovariancancer led by @DrDaleGarsed. With thanks to all our collaborators and patients from 🇦🇺 & 🌎
Dr Dale Garsed@DrDaleGarsed1 Aug 2024
In a large international study of more than 7000 patients with #OvarianCancer, we found that combined loss of RB1 protein & BRCA gene mutation predicts 🔼 immunologic responses and long-term survival in the high-grade serous subtype. Online NOW @CCR_AACR doi.org/10.1158/1078-0432.CC…

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term...

AbstractPurpose:. The purpose of this study was to evaluate RB1 expression and survival across ovarian carcinoma histotypes and how co-occurrence of BRCA1 or BRCA2 (BRCA) alterations and RB1 loss...

aacrjournals.org
1
1
11
396
@PeterMacRes @UniMelb @UNSW @unibern @UCalgary @DaffodilCentre @Sydney_Uni @WestmeadInst
1
95
Read the latest research from the Christie lab @PeterMacRes on MHCII and whole genome duplication in ovarian cancer, published with @SpringerNature in @NatureComms nature.com/articles/s41467-0…

Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous...

Nature Communications - There is high prevalence of whole genome duplication (WGD) in high grade serous ovarian cancer. Here, the authors compare tumours with and without WGD and find that those...

nature.com
3
10
3
32
2,065
This symposium is going to be amazing. Want to join our PREDICT network? Pls come along. 👇
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
5
13
1,136
Congratulations to ⁦@g_auyeung⁩ and Dr Sathya Manoharan and team from ⁦@PeterMacCC⁩ ⁦@BowtellLab⁩ on completing and presenting this investigator- initiated BEACON trial showing interesting activity of a non- chemo combo in platinum resistant ovarian cancer
1
1
1
36
719
@BowtellLab’s Prof David Bowtell and Dr Rachel Delahunty will be joining @ocrfaustralia on May 8. Register via link below to hear the latest …
This Post is from an account that no longer exists. Learn more
2
7
422
Congratulations @DrDaleGarsed! Fantastic!
Dr Dale Garsed@DrDaleGarsed15 Dec 2023
Incredibly excited and grateful to receive an @nhmrc Ideas Grant to explore immune responses in patients with #OvarianCancer who are exceptionally long-term survivors, in collaboration with @BowtellLab @PeterMacCC & the Nelson Lab @BCCancer tinyurl.com/ypahuf67
1
9
277
Researchers from @BowtellLab, AOCS and Christie Labs met today with a team of passionate #ovariancancerconsumers & advocates we’ve engaged with for a number of years now. A lovely catch up, research update & discussion about the important role consumers play in #advancingresearch
1
1
14
960
Congratulations @g_auyeung ! 👏👏
Linda Mileshkin@LindaMileshkin20 Nov 2023
Congratulations to ⁦@g_auyeung⁩ for winning one of the ⁦@PeterMacCC⁩ awards this afternoon for World’s best cancer discovery and translation. For finding better options for CCNE over-expressed or amplified ovarian cancer! ⁦@BowtellLab⁩
1
15
685
Next in the spotlight at #IGCS2023 Dr Nikki Burdett’s work from her thesis in @DrLizChristie lab illustrating the tumour heterogeneity in HGSOC from primary to end stage disease @PMPostdocs @PeterMacRes 🔥
2
14
740
Replying to @DrDaleGarsed
@DrDaleGarsed @DrKathAlsop @BowtellLab studies of exceptional responders being highlighted by Dr Kathleen Moore at #IGCS2023 in discussion of PARPi, are they for everyone? @PMPostdocs @PeterMacRes
3
9
448
Thanks to the #IGCS2023 scientific committee for selecting our IGNITE abstract as best oral abstract! Proud to be representing @anzgog @PeterMacCC and thx to the whole study team especially @LindaMileshkin @BowtellLab for giving me the opportunity to lead the study
6
9
1
67
3,757
👏👏👏 Congratulations @g_auyeung!
Linda Mileshkin@LindaMileshkin5 Nov 2023
So pleased and proud to see @g_auyeung win the award for best oral abstract at #IGCS2023 this morning in Seoul. A tribute to all his hard work towards improving outcomes for women with CCNE1 driven ovarian cancer who don’t do so well with SOC @BowtellLab @PeterMacRes @anzgog
9
362
Prof David Bowtell @bowtelllab was honoured to give the AACR Foundation Special Conference on Ovarian Cancer opening keynote address. He shared where his lab has directed their efforts to maximise returns in #OvarianCancer #research #cancer #GynecologicalCancer
4
29
1,460
Congratulations to @BowtellLab’s Dr Rachel Delahunty! Rachel’s PhD described the TRACEBACK genetic testing program, which aims to utilise genetic testing to help reduce the number of #ovariancancer and other hereditary cancer diagnoses in Australia 🧬
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
3
4
24
1,605
BowtellLab retweeted
ANZGOG
@anzgog8 Sep 2023
Collaboration is a necessity in ensuring a relevant, vibrant, impactful research agenda 🤝 One particular example of collaboration at ANZGOG is between scientists and clinicians, who work together to advance research 'bench to bedside' for gynaecological cancer patients.
4
20
3,964
May 8 is #WorldOvarianCancerDay … to find out more about just one of the projects we are working on here at @BowtellLab @PeterMacRes @PeterMacCC see below 👀👇. Together we can improve outcomes for all patients.
EXPeditions@joinExpeditions2 Jan 2023
Why do some people survive cancer? David Bowtell, Co-head of the Women’s Cancer Program at the Peter MacCallum Cancer Centre, has been studying ovarian cancer patients who have beaten the odds. #OvarianCancer #CancerSurvivors @PeterMacCC bit.ly/35PGlhY
4
12
1,865
We're so thrilled to have three incredible staff recognised at the annual @anzgog awards last night. Congratulations @LindaMileshkin, @BowtellLab and Dr Nikki Burdett! Read more: petermac.org/news/peter-mac-… | #ANZGOG2023ASM @PeterMacCC
1
2
24
1,256
👏👏👏
Peter Mac Cancer Centre@PeterMacCC24 Mar 2023
Three Peter Mac staff were recognised with prestigious awards at the @anzgog Annual Scientific Meeting overnight. Congratulations to Professor @LindaMileshkin, Professor David Bowtell (@BowtellLab) and Dr Nikki Burdett. Read more: petermac.org/news/peter-mac-…
9
565
The incredible contributions of @PeterMacCC @PeterMacRes Prof David Bowtell @BowtellLab & Prof @LindaMileshkin for their outstanding contributions to gynae cancer research & practice recognised by @anzgog ! And up and coming ⭐️ Dr Nikki Burdett (Christie Lab)
George Auyeung@g_auyeung23 Mar 2023
So immensely proud of Dr Nikki Burdett, @LindaMileshkin and Professor David Bowtell for being recognised at #ANZGOG2023ASM for their amazing contributions to research in Gynae cancers and improving the lives of women with Gynae cancer @BowtellLab @PeterMacCC @PeterMacRes @anzgog
1
24
1,084
Load more